Brief: Formosa Pharmaceuticals Announces Development Collaboration Agreement With Eyenovia
15/02/2023 08:01
Feb 15 (Reuters) - Formosa Pharmaceuticals Inc
6838.TWO :
* FORMOSA PHARMACEUTICALS ANNOUNCES DEVELOPMENT
COLLABORATION
AGREEMENT WITH EYENOVIA
Source text for Eikon: ID:nPn9t0zv8a
Further company coverage: 6838.TWO
((reuters.briefs@thomsonreuters.com;))
Recent news on Formosa Pharmaceuticals
See all newsBrief: Formosa Pharmaceuticals Announces Licensing Agreement With Rxilient
Brief: Harrow Acquires U.S. Commercial Rights To Byqlovi™ From Formosa Pharmaceuticals
US FDA approves Eyenovia's eye drug, Formosa Pharma says (updated)
US FDA approves Eyenovia's eye drug, Formosa Pharma says
Brief: Formosa Pharmaceuticals And Aimmax Therapeutics Receive FDA Approval For Clobetasol Propionate Ophthalmic Suspension 0.05%